NCT05386524 Sintilimab and Bevacizumab Biosimilar Combined With PLD in mTNBC Status UNKNOWN Phase PHASE2
NCT05385146 Effect of Chan-Chuang Qigong With Breathing Meditation on Quality of Life in Patients With Breast Cancer Status COMPLETED Phase NA
NCT05384119 Phase 1b/2 Study of TTI-101 in Combination for Patients With Metastatic Hormone Receptor-Positive and HER2-Negative Breast Cancer Status TERMINATED Phase PHASE1
NCT05381038 Optimizing and Personalising Azacitidine Combination Therapy for Treating Solid Tumours QPOP and CURATE.AI Status RECRUITING Phase PHASE1/PHASE2
NCT05378204 Study Evaluating DNA Double-strand Breaks (DSBs) REpair Factors (POLQ, Shieldin Complex and 53BP1) Expression as Biomarker of PARP Inhibitor Resistance in Patients With Deleterious Germline Mutation in BRCA 1/2 and HER2-negative, Metastatic or Locally Advanced Breast Cancer. Status RECRUITING Phase NA
NCT05374512 A Study of Dato-DXd Versus Investigator's Choice Chemotherapy in Patients With Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer, Who Are Not Candidates for PD-1/PD-L1 Inhibitor Therapy (TROPION-Breast02) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05373069 BENEFIT OF MECHANICAL ISCHEMIC PRECONDITIONING ON TOLERANCE OF ADIPOSE TISSUE TO ISCHEMIA REPERFUSION OF TYPE DIEP (DEEP INFERIOR EPIGASTRIC PERFORATOR) FREE FLAPS. Status COMPLETED Phase NA
NCT05371860 Radiation Omission in Patients With HER2 Overexpressing Tumors With Pathologic Complete Response Status WITHDRAWN Phase PHASE2
NCT05371847 Identifying Prognostic Variables for Persistent UL Dysfunctions After Breast Cancer Treatment -Reliability and Validity Status RECRUITING Phase NA
NCT05370300 SNAPS Breast Cancer Patient Study Breast Cancer Patients Status NOT_YET_RECRUITING Phase N/A
NCT05369546 Lesion Composition and Quantitative Imaging Analysis on Breast Cancer Diagnosis Status RECRUITING Phase N/A
NCT05366881 cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease Status RECRUITING Phase N/A